These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15989681)

  • 1. Posttransplant lymphoproliferative disease presenting as adrenal insufficiency: case report.
    Khan A; Ortiz J; Jacobson L; Reich D; Manzarbeitia C
    Exp Clin Transplant; 2005 Jun; 3(1):341-4. PubMed ID: 15989681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Burra P; Buda A; Livi U; Rigotti P; Zanus G; Calabrese F; Caforio A; Menin C; Canova D; Farinati F; Luciana Aversa SM
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1065-70. PubMed ID: 16957512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
    Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant Epstein-Barr virus (EBV)-associated T-cell lymphoproliferative disorder with hemophagocytosis following autologous peripheral blood stem cell transplantation for relapsed angioimmunoblastic T-cell lymphoma.
    Awaya N; Adachi A; Mori T; Kamata H; Nakahara J; Yokoyama K; Yamada T; Kizaki M; Sakamoto M; Ikeda Y; Okamoto S
    Leuk Res; 2006 Aug; 30(8):1059-62. PubMed ID: 16330097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting with skin involvement after CD34-selected autologous peripheral blood stem cell transplantation.
    Takahashi S; Watanabe D; Miura K; Ozawa H; Tamada Y; Hara K; Matsumoto Y
    Eur J Dermatol; 2007; 17(3):242-4. PubMed ID: 17478388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].
    Liu QF; Fan ZP; Luo XD; Zhang Y; Sun J
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(44):3123-6. PubMed ID: 19159594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N; Torabineghad S; Rakei M
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus-associated B cell lymphoproliferative disorder complicated in adult T-cell leukemia].
    Tanaka Y; Kondo T; Kishimoto W; Kanda J; Tashima M; Mizumoto C; Ichinohe T; Ishikawa T; Uchiyama T; Haga H; Manabe T
    Rinsho Ketsueki; 2008 Apr; 49(4):263-9. PubMed ID: 18516870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fulminant, rapidly reversible hepatitis and life-threatening anaphylaxis following rifampicin in an HIV-positive female patient with latent adrenal cortex insufficiency].
    Canova CR; Kuhn M; Zellweger U; Reinhart WH
    Schweiz Med Wochenschr; 1996 Mar; 126(10):392-7. PubMed ID: 8643939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
    Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion.
    Vakiani E; Nandula SV; Subramaniyam S; Keller CE; Alobeid B; Murty VV; Bhagat G
    Hum Pathol; 2007 Feb; 38(2):315-25. PubMed ID: 17134734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of fulminant post-transplant lymphoproliferative disorder and septicemia.
    Gouya G; Hartmann G; Faè P; Tauber M; Holzmüller H; Benzer W; Lang A; Schuster A; Drexel H; Offner FA
    Clin Transplant; 2006; 20(2):261-4. PubMed ID: 16640537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkitt's lymphoma following a pediatric liver transplantation: predictive negative value of serologic response to Epstein-Barr virus.
    Yilmaz A; Hazar V; Akçam M; Inanç-Gürer E; Ceken K; Artan R
    Turk J Pediatr; 2007; 49(4):434-6. PubMed ID: 18246749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: fatal lymphoproliferative disease seven weeks after liver transplantation.
    Hoon V; Fasy TM; Kheiri S; Theise N; Lin CS; Klion F; Schwartz M; Miller C; Thung SN
    Mt Sinai J Med; 1994 Jan; 61(1):72-6. PubMed ID: 8183298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case.
    Shitrit D; Shitrit AB; Dickman R; Sahar G; Saute M; Kramer MR
    Dis Colon Rectum; 2005 Nov; 48(11):2144-7. PubMed ID: 16086224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Roque J; Rios G; Humeres R; Volpi C; Herrera JM; Schultz M; Rios H; Rius M; Salgado C; Hepp J
    Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant lymphoproliferative disorder and tonsillectomy in a pediatric liver transplant population.
    Nalesnik MA
    Liver Transpl; 2001 May; 7(5):466-8. PubMed ID: 11349270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.